|Day Low/High||2.14 / 2.23|
|52 Wk Low/High||1.46 / 2.90|
Investment miscues can be just as important as successes, provided we carry lessons away from them.
These names frequently trade at low multiples to current assets and may (but may not) be worthy of purchase.
Just five non-biotech names trade below net current asset value.
But sometimes it just takes patience, and a bit of work, to make them smell sweet.
Now known as ModusLink, the struggling firm has some positives.
These stocks traded below net current asset value a few months ago, but two of them have graduated.
Our search for companies trading below net current asset value has produced a few more names.